(3S, 4R)-4-(4-fluorophenyl)-3-(hydroxymethyl)piperidinium chloride

被引:1
|
作者
Nirmala, M. [1 ]
Sreekanth, B. R. [1 ]
Vishweshwar, Peddy [1 ]
Babu, J. Moses [1 ]
Anjaneyulu, Y. [2 ]
机构
[1] Dr Reddys Labs Ltd, Dept Analy Res, Hyderabad 500049, Andhra Pradesh, India
[2] Jawaharlal Nehru Technol Univ, Ctr Atmospher Sci, Hyderabad 500072, Andhra Pradesh, India
来源
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE | 2008年 / 64卷
关键词
D O I
10.1107/S1600536808008593
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
The title compound, C12H17FNO+center dot Cl-, is a degradation impurity of paroxetine hydrochloride hemihydrate (PAXIL), an antidepressant belonging to the group of drugs called selective serotonin reuptake inhibitors (SSRIs). Similar to the paroxetine hydrochloride salt with protonation having taken place on the basic piperidine ring, the degradation impurity also exists as the hydrochloride salt. The cyclic six-membered piperidinium ring adopts a chair conformation with the hydroxymethyl and 4-fluorophenyl groups in the equatorial positions. The ions form a tape along the b axis through charge-assisted N+-H center dot center dot center dot Cl- hydrogen bonds; these tapes are connected by O-H center dot center dot center dot Cl- hydrogen bonds along the a axis.
引用
收藏
页码:O800 / U1392
页数:9
相关论文
共 50 条
  • [1] Enantiomeric analysis of (3S,4R)-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine by 19F NMR spectroscopy
    Navrátilová, H
    MAGNETIC RESONANCE IN CHEMISTRY, 2001, 39 (11) : 727 - 730
  • [2] (3S,4R)-4-[4-(Benzyloxy)phenyl]-3-(4-fluorophenyl)1-[(S)-1-(4-methoxyphenyl)ethyl]azetidin-2-one
    Wu, Jin-Chang
    Sun, Jing-Bo
    Xu, Xian-Xiu
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : O2844 - O2845
  • [3] An efficient and stereoselective synthesis of (3S,4R)-(-)-trans-4-(4′-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine
    Somaiah, Sripathi
    Sashikanth, Suthrapu
    Raju, Veeramalla
    Reddy, Karnati Venugopal
    TETRAHEDRON-ASYMMETRY, 2011, 22 (01) : 1 - 3
  • [4] Enantiomeric enrichment of (+)-(3R,4S)-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine by crystallization
    Navrátilová, H
    Potácek, M
    ENANTIOMER, 2001, 6 (06): : 333 - 337
  • [5] 4-[4-dimethylamino-1-(4-fluorophenyl)-1-hydroxy-butyl]-3-(hydroxymethyl)benzonitrile
    Gu, JM
    Wang, YW
    Hu, XR
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2005, 61 : O2691 - O2693
  • [6] (3S,4R)-3-甲基-4-苯基哌啶-4-羧酸乙酯的合成
    王李平
    赵立博
    张宏宇
    张月成
    精细石油化工, 2019, (03) : 1 - 4
  • [7] 4-[3-(4-Fluorophenyl)-5-isopropylisoxazol-4-yl]pyridine
    Peifer, Christian
    Abadleh, Mohammed
    Schollmeyer, Dieter
    Laufer, Stefan
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : O3707 - O3709
  • [8] An efficient stereoselective synthesis of (3S,4R)-4-(hydroxymethyl)pyrrolidin-3-ol from (S)-diethylmalate
    Kotian, PL
    Chand, P
    TETRAHEDRON LETTERS, 2005, 46 (19) : 3327 - 3330
  • [9] SHORT SYNTHESIS OF (3S,4R)-3-HYDROXY-4-HYDROXYMETHYL-4-BUTANOLIDE AND (3R,4R)-3-HYDROXY-4-HYDROXYMETHYL-4-BUTANOLIDE, 2 LACTONES FROM LEVOGLUCOSENONE
    MATSUMOTO, K
    EBATA, T
    KOSEKI, K
    OKANO, K
    KAWAKAMI, H
    MATSUSHITA, H
    BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 1995, 68 (02) : 670 - 672
  • [10] Crystal structure of (3R,4S)-4-(4-(benzyloxy)phenyl)-1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)azetidin-2-one, C31H25F2NO3
    Yang, Zhao
    Wang, Zhi-Xiang
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2013, 228 (03): : 315 - 316